Abstract
This study sought to explore the predictive value of the insulin-like growth factor (IGF) binding proteins (IGFBP) as markers of response in ovarian cancer patients treated with the aromatase inhibitor letrozole.
Original language | English |
---|---|
Pages (from-to) | 1438-44 |
Number of pages | 7 |
Journal | Clinical Cancer Research |
Volume | 13 |
Issue number | 5 |
DOIs | |
Publication status | Published - 1 Mar 2007 |
Keywords / Materials (for Non-textual outputs)
- Antineoplastic Agents
- CA-125 Antigen
- Cell Line, Tumor
- Drug Resistance, Neoplasm
- Estradiol
- Female
- Humans
- Immunohistochemistry
- Insulin-Like Growth Factor Binding Protein 3
- Insulin-Like Growth Factor Binding Protein 4
- Insulin-Like Growth Factor Binding Protein 5
- Insulin-Like Growth Factor Binding Proteins
- Nitriles
- Ovarian Neoplasms
- RNA, Messenger
- Receptors, Estrogen
- Reverse Transcriptase Polymerase Chain Reaction
- Triazoles